Therapeutics: Vascular endothelial growth factor B (VEGF-B); vascular endothelial growth factor receptor 1 (FLT1; VEGFR-1)

Endocrine/metabolic disease

INDICATION: Metabolic syndrome; obesity

Mouse studies suggest that promoting VEGF-B and inhibiting FLT1 could help treat metabolic syndrome and

Read the full 192 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE